Literature DB >> 19839005

The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.

Oscar Gonzalez1, Vanessa Fontanes, Santanu Raychaudhuri, Rachel Loo, Joseph Loo, Vaithilingaraja Arumugaswami, Ren Sun, Asim Dasgupta, Samuel W French.   

Abstract

UNLABELLED: The hepatitis C viral (HCV) genome is translated through an internal ribosome entry site (IRES) as a single polyprotein precursor that is subsequently cleaved into individual mature viral proteins. Nonstructural protein 5A (NS5A) is one of these proteins that has been implicated in regulation of viral genome replication, translation from the viral IRES and viral packaging. We sought to identify cellular proteins that interact with NS5A and determine whether these interactions may play a role in viral production. Mass spectrometric analysis of coimmunoprecipitated NS5A complexes from cell extracts identified heat shock proteins (HSPs) 40 and 70. We confirmed an NS5A/HSP interaction by confocal microscopy demonstrating colocalization of NS5A with HSP40 and with HSP70. Western analysis of coimmunoprecipitated NS5A complexes further confirmed interaction of HSP40 and HSP70 with NS5A. A transient transfection, luciferase-based, tissue culture IRES assay demonstrated NS5A augmentation of HCV IRES-mediated translation, and small interfering RNA (siRNA)-mediated knockdown of HSP70 reduced this augmentation. Treatment with an inhibitor of HSP synthesis, Quercetin, markedly reduced baseline IRES activity and its augmentation by NS5A. HSP70 knockdown also modestly reduced viral protein accumulation, whereas HSP40 and HSP70 knockdown both reduced infectious viral particle production in an HCV cell culture system using the J6/JFH virus fused to the Renilla luciferase reporter. Treatment with Quercetin reduced infectious particle production at nontoxic concentrations. The marked inhibition of virus production by Quercetin may partially be related to reduction of HSP40 and HSP70 and their potential involvement in IRES translation, as well as viral morphogenesis or secretion.
CONCLUSION: Quercetin may allow for dissection of the viral life cycle and has potential therapeutic use to reduce virus production with low associated toxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839005      PMCID: PMC3846025          DOI: 10.1002/hep.23232

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  43 in total

1.  Novel fluorescence-based screen to identify small synthetic internal ribosome entry site elements.

Authors:  A Venkatesan; A Dasgupta
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  [Surgical procedure of gynecologic malignances in patients over 70 years].

Authors:  L Pan; H Huang; L Lian
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2001-10

Review 3.  Replication of hepatitis C virus.

Authors:  Darius Moradpour; François Penin; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2007-05-08       Impact factor: 60.633

4.  Silver stain removal using H2O2 for enhanced peptide mass mapping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Lloyd W Sumner; Barbara Wolf-Sumner; Steven P White; Victor S Asirvatham
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

Review 5.  Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.

Authors:  Asim Dasgupta; Saumitra Das; Raquel Izumi; Arun Venkatesan; Bhaswati Barat
Journal:  FEMS Microbiol Lett       Date:  2004-05-15       Impact factor: 2.742

Review 6.  A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties.

Authors:  M Harwood; B Danielewska-Nikiel; J F Borzelleca; G W Flamm; G M Williams; T C Lines
Journal:  Food Chem Toxicol       Date:  2007-06-07       Impact factor: 6.023

7.  Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors.

Authors:  A Shrivastava; S K Manna; R Ray; B B Aggarwal
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 8.  The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions.

Authors:  Mads Daugaard; Mikkel Rohde; Marja Jäättelä
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

Review 9.  Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication?

Authors:  Ying Huang; Kirk Staschke; Raffaele De Francesco; Seng-Lai Tan
Journal:  Virology       Date:  2007-04-02       Impact factor: 3.616

10.  Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Authors:  Timothy L Tellinghuisen; Katie L Foss; Jason C Treadaway; Charles M Rice
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

View more
  62 in total

Review 1.  Medicinal plants against hepatitis C virus.

Authors:  Usman A Ashfaq; Sobia Idrees
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.

Authors:  L Yao; H Dong; H Zhu; D Nelson; C Liu; L Lambiase; X Li
Journal:  J Viral Hepat       Date:  2011-03-16       Impact factor: 3.728

3.  Effects of quercetin on CDK4 mRNA and protein expression in A549 cells infected by H1N1.

Authors:  Qiaofeng Wan; Hao Wang; Yuan Lin; Ligang Gu; Mei Han; Zhiwei Yang; Yanli Zhang; Rui Ma; Li Wang; Zhisheng Wang
Journal:  Biomed Rep       Date:  2013-07-19

4.  Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly.

Authors:  Ronik Khachatoorian; Rana Riahi; Ekambaram Ganapathy; Hao Shao; Nicole M Wheatley; Christopher Sundberg; Chun-Ling Jung; Piotr Ruchala; Asim Dasgupta; Vaithilingaraja Arumugaswami; Jason E Gestwicki; Samuel W French
Journal:  Int J Antimicrob Agents       Date:  2016-03-02       Impact factor: 5.283

5.  Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.

Authors:  Syo Nakajima; Koichi Watashi; Hirofumi Ohashi; Shinji Kamisuki; Jesus Izaguirre-Carbonell; Andrew Tae-Jun Kwon; Harukazu Suzuki; Michiyo Kataoka; Senko Tsukuda; Maiko Okada; Meng Ling Moi; Toshifumi Takeuchi; Minetaro Arita; Ryosuke Suzuki; Hideki Aizaki; Takanobu Kato; Tadaki Suzuki; Hideki Hasegawa; Tomohiko Takasaki; Fumio Sugawara; Takaji Wakita
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  Inhibitors of endoplasmic reticulum alpha-glucosidases potently suppress hepatitis C virus virion assembly and release.

Authors:  Xiaowang Qu; Xiaoben Pan; Jessica Weidner; Wenquan Yu; Dominic Alonzi; Xiaodong Xu; Terry Butters; Timothy Block; Ju-Tao Guo; Jinhong Chang
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

Review 7.  Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.

Authors:  Gisa Gerold; Janina Bruening; Bettina Weigel; Thomas Pietschmann
Journal:  Mol Cell Proteomics       Date:  2017-01-11       Impact factor: 5.911

8.  Protective effect of quercetin, EGCG, catechin and betaine against oxidative stress induced by ethanol in vitro.

Authors:  Joan Oliva; Fawzia Bardag-Gorce; Brittany Tillman; Samuel W French
Journal:  Exp Mol Pathol       Date:  2011-02-23       Impact factor: 3.362

9.  Systematic analysis of enhancer and critical cis-acting RNA elements in the protein-encoding region of the hepatitis C virus genome.

Authors:  Derrick Chu; Songyang Ren; Stacy Hu; Wei Gang Wang; Aparna Subramanian; Deisy Contreras; Vidhya Kanagavel; Eric Chung; Justine Ko; Ranjit Singh Amirtham Jacob Appadorai; Sanjeev Sinha; Ziba Jalali; David W Hardy; Samuel W French; Vaithilingaraja Arumugaswami
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  Entry of hepatitis C virus into the cell: a therapeutic target.

Authors:  José Antonio Del Campo; Ángela Rojas; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.